I70.593

Clinical Causes: Progressive accumulation of fats, cholesterol, and other substances in the blood vessel walls Development of plaque within the grafts, leading to narrowing or blockage Damage to blood vessel walls from high blood pressure, smoking, or chronic inflammation Diabetes mellitus, which accelerates atherosclerosis High levels of LDL cholesterol, contributing to plaque formation Previous bypass surgeries using non-autologous biological grafts that may be prone to degenerative changes over time

Key Symptoms: Leg pain or cramping during physical activity, known as intermittent claudication Numbness or weakness in the legs Coldness or pallor in the affected legs or feet Diminished or absent pulses in the legs Open sores or ulcers on the legs or feet that heal slowly or not at all Change in color or texture of the skin on the legs Feeling of fatigue or heaviness in the legs after exertion

Diagnosis Path: Doppler ultrasound to assess blood flow in the legs Angiography, using imaging techniques such as CT or MRI, to visualize the blood vessels and identify blockages or narrowing Ankle-brachial index (ABI) test to compare blood pressure in the ankles with that in the arms Blood tests to evaluate cholesterol levels and other risk factors

Treatment Protocols: Lifestyle modifications such as smoking cessation, regular exercise, and dietary changes to lower cholesterol and blood pressure Medications to control blood pressure, lower cholesterol (statins), and manage blood sugar levels in diabetics Antiplatelet agents to reduce the risk of blood clots Endovascular procedures like angioplasty and stenting to open narrowed or blocked grafts Surgical interventions to bypass or replace the affected grafts if necessary Regular follow-up and monitoring for progression of the disease